The long road after breast cancer: survivorship issues and long-term treatment effects in young women
Abstract
Advances in early detection and treatment have significantly improved survival rates in young women with breast cancer, leading to a growing population of long-term survivors. However, survivorship in this population is characterized by a unique and complex set of challenges that extend well beyond the completion of active treatment. This review aims to provide a comprehensive overview of the long-term physical, psychological, reproductive, and social effects of breast cancer and its treatment in young survivors, highlighting the need for tailored, age-specific survivorship care. Young breast cancer survivors are particularly vulnerable to treatment-related sequelae due to the interaction between therapy-related toxicities and critical life stages, including family planning, career development, and relationship building. Common long-term physical effects include bone density loss associated with premature ovarian insufficiency, cognitive dysfunction, and persistent cancer-related fatigue. In addition, endocrine therapies and treatment-induced menopause contribute to vasomotor symptoms (VMS), sleep disturbances, weight gain, and sexual dysfunction, all of which can significantly impair quality of life. Psychological distress is highly prevalent in this population, with elevated rates of anxiety, depression, post-traumatic stress, and fear of cancer recurrence. Fertility and reproductive health concerns represent a central issue, encompassing fertility preservation, pregnancy after breast cancer, and the safety of interrupting endocrine therapy. Social challenges, including difficulties with return to work, financial toxicity, and disruptions in intimate relationships, further compound the survivorship burden. Despite increasing recognition of these issues, many remain underdiagnosed and undertreated. A multidisciplinary, patient-centered approach is essential, integrating oncologic care with primary care, reproductive endocrinology, mental health services, and supportive care interventions. Early counseling, routine screening, and proactive management of long-term effects are key components of optimal survivorship care. By synthesizing current evidence, this review underscores the importance of developing comprehensive survivorship strategies tailored to the specific needs of young breast cancer survivors, with the ultimate goal of improving long-term outcomes and enabling patients not only to survive but to thrive after breast cancer.
Related
- Which quality of life issues are important to patients with metastatic breast cancer: Phase 1 and 2 development of European Organisation for Research and Treatment of Cancer metastatic breast cancer module (EORTC QLQ-MBR)
- Neurokinin-3 receptor antagonists for vasomotor symptoms in menopause and breast cancer survivorship.
- From cN2 to ypN0: Nodal Downstaging After Neoadjuvant Treatment in Breast Cancer—A Retrospective Cohort Study from a Tertiary Cancer Center
- Pre-Treatment CD44 and CD47 Expression and Pathological Complete Response After Neoadjuvant Therapy in Breast Cancer: An Exploratory Single-Center Study
- Impact of Metronomic Capecitabine after Standard Treatment in Non Metastatic Triple Negative Breast Cancer: A Retrospective Study
BibTeX
@article{pagliuca2026long,
title = {{The long road after breast cancer: survivorship issues and long-term treatment effects in young women}},
author = {Martina Pagliuca and Roberto Buonaiuto and Annarita Verrazzo and Sara Parola and Margherita Tafuro and Claudia Calderaio and Claudia Martinelli and Rossana Di Rienzo and Miriam Pirolo and Christian Zurlo and Ornella Tinelli and Roberta Valente and Luisa Cirillo and Martina Autiero and Maria Luisa d'Aulisio Garigliota and Raffaella Di Monda and Carmine de Angelis and Michelino de Laurentiis},
journal = {Frontiers in Oncology},
year = {2026},
month = nov,
doi = {10.3389/fonc.2026.1840152},
url = {https://hal.science/hal-05850373v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - The long road after breast cancer: survivorship issues and long-term treatment effects in young women
AU - Martina Pagliuca
AU - Roberto Buonaiuto
AU - Annarita Verrazzo
AU - Sara Parola
AU - Margherita Tafuro
AU - Claudia Calderaio
AU - Claudia Martinelli
AU - Rossana Di Rienzo
AU - Miriam Pirolo
AU - Christian Zurlo
AU - Ornella Tinelli
AU - Roberta Valente
AU - Luisa Cirillo
AU - Martina Autiero
AU - Maria Luisa d'Aulisio Garigliota
AU - Raffaella Di Monda
AU - Carmine de Angelis
AU - Michelino de Laurentiis
PY - 2026
DA - 2026/11/03
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.1840152
UR - https://hal.science/hal-05850373v1
AB - Advances in early detection and treatment have significantly improved survival rates in young women with breast cancer, leading to a growing population of long-term survivors. However, survivorship in this population is characterized by a unique and complex set of challenges that extend well beyond the completion of active treatment. This review aims to provide a comprehensive overview of the long-term physical, psychological, reproductive, and social effects of breast cancer and its treatment in young survivors, highlighting the need for tailored, age-specific survivorship care. Young breast cancer survivors are particularly vulnerable to treatment-related sequelae due to the interaction between therapy-related toxicities and critical life stages, including family planning, career development, and relationship building. Common long-term physical effects include bone density loss associated with premature ovarian insufficiency, cognitive dysfunction, and persistent cancer-related fatigue. In addition, endocrine therapies and treatment-induced menopause contribute to vasomotor symptoms (VMS), sleep disturbances, weight gain, and sexual dysfunction, all of which can significantly impair quality of life. Psychological distress is highly prevalent in this population, with elevated rates of anxiety, depression, post-traumatic stress, and fear of cancer recurrence. Fertility and reproductive health concerns represent a central issue, encompassing fertility preservation, pregnancy after breast cancer, and the safety of interrupting endocrine therapy. Social challenges, including difficulties with return to work, financial toxicity, and disruptions in intimate relationships, further compound the survivorship burden. Despite increasing recognition of these issues, many remain underdiagnosed and undertreated. A multidisciplinary, patient-centered approach is essential, integrating oncologic care with primary care, reproductive endocrinology, mental health services, and supportive care interventions. Early counseling, routine screening, and proactive management of long-term effects are key components of optimal survivorship care. By synthesizing current evidence, this review underscores the importance of developing comprehensive survivorship strategies tailored to the specific needs of young breast cancer survivors, with the ultimate goal of improving long-term outcomes and enabling patients not only to survive but to thrive after breast cancer.
SN - 2234-943X
ER -